S ince the first reported clinical implantation of a transcatheter valve in 2002, 1 the rapidity of assimilation into the clinical arena of this novel technology has been astonishing. Transcatheter aortic valve implantation, either retrograde through a transfemoral approach or antegrade through a transapical approach, has become a clinical reality in the treatment critical aortic stenosis in high-risk patients. Commercialization of both self-expanding and balloon expandable platforms in Europe, as an alternative to conventional aortic valve replacement, has led to the implantation of more than 2000 such valves worldwide. Early clinical results are positive and have generated intense interest in this technology, along with intense scrutiny. Despite the rapid advances, procedural mortality remains high in comparison with some traditional populations having aortic valve replacement. It cannot be over emphasized, however, that the patients undergoing these procedures are unlike those previously described in the surgical literature in terms of comorbidities, estimated operative mortality, and degree of frailty or debility.
strated that when you control for the incidence of coronary artery disease in transcatheter patients, surgical approach (transapical or transfemoral) is not an independent predictor of mortality. The ongoing Food and Drug Administration sponsored PARTNER Trial comparing transcatheter aortic valve implantation with conventional surgery or optimal medical management in high-risk patients with critical aortic stenosis also utilizes a transfemoral first treatment algorithm. Notable institutions in Europe and Canada using a "transapical first" approach as their primary treatment modality, for "all comers" including those with severe peripheral vascular disease, have reported outcomes equivalent to the best transfemoral sites.
It is important to appreciate that each approach has its associated advantages and disadvantages. Compared with the transfemoral approach, the transapical procedure demonstrates more accurate positioning of the valve with less movement on deployment, reduced likelihood of embolic showering with passage of the delivery system around the aortic arch, and minimal risk of vascular injury. In addition, device profile is not a limiting factor for the addition of ancillary devices to the delivery system to capture embolic debris or optional coverings for the prosthesis to reduce paravalvular leak. Conversely, the transfemoral approach is less invasive, better tolerated in patients with severe pulmonary disease and reduced lung function and demonstrates a faster learning curve because of the overlap of the skill sets of interventional cardiologists and the technical demands of the procedure. It is also worth noting that embolic failure of a transapical proce-dure is usually into the ventricle mandating converting to open removal of the prosthesis and conventional valve replacement. While embolic failure with a transfemoral procedure tends to be into the ascending aorta, and it can be managed percutaneously by dragging the valve distally and safely deploying it into the descending thoracic aorta. Subsequently, if the patient remains hemodynamically stable a second attempt at transfemoral placement can be attempted. These events become anecdotal once the learning curve has been surmounted with both the techniques.
At the end of the day, each approach will have to stand on its own merits and demonstrate comparative effectiveness with conventional valve replacement. It must again be emphasized however that each approach must be evaluated independent of the other as they are treating two different populations of patients. Demonstration of the Kaplan-Meir survival between transfemoral and transapical patients within studies or institutions that have a predisposed treatment strategy should come to an end. Comparison of the transapical and transfemoral approaches can only be achieved by providing a level playing field, such as a randomized trial in which study patients were equally good candidates for either technique. The outcome of such a "bake-off" between these two approaches would unquestionably illustrate the value of both of these procedures.
